Skip to main content
ABOS logo

ABOS

Acumen Pharmaceuticals, Inc.

$0.19

1.71%

Trade Ideas Performance

Latest Closed Trade Idea

$0.19

1.71%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

46

Social

37

About

Events of Acumen Pharmaceuticals, Inc. (ABOS)

The past six months saw significant events for Acumen Pharmaceuticals, Inc.'s stock. On October 26, 2026, the company reported a narrower-than-expected net loss for Q3 2026. However, on October 30, 2026, it was announced that the Phase 2 ALTITUDE-AD clinical trial of sabirnetug (ACU193) for early Alzheimer's disease failed to meet its primary or key secondary endpoints, leading to the decision to discontinue further development of sabirnetug. This critical setback caused Acumen's stock price to plunge over 80-90% in premarket trading, reaching a 52-week low around October 29, 2026. The event triggered multiple analyst downgrades from BofA Securities, Stifel, BTIG, and Lucid Capital. The stock's 52-week high was $3.60, and its 52-week low was $0.19.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)